Jobs / United States / Astrazeneca Pharmaceuticals Lp

Astrazeneca Pharmaceuticals Lp

Scientist, Cell Therapy Bioscience

US - Gaithersburg - MD Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles12 certified filings for “Assoc.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
12 certified filings for “Assoc. Princ. Scientist, Vector Engineering & Cell Line Dev.” (Molecular and Cellular Biologists) in MD: $103k–$158k, median $136k. Most were filed at wage level IV (33%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Scientist, Cell Therapy Bioscience   About AstraZeneca   At AstraZeneca, we are driven by our ambition to transform science into life-changing medicines for patients. We bring together deep biological insight, innovative technologies and data-driven approaches to tackle complex scientific challenges and accelerate the discovery and development of new therapies. We foster a collaborative and inclusive environment where diverse perspectives, scientific rigor and bold thinking help us push the boundaries of what is possible.  Within Cell Therapy, we are advancing the next generation of engineered cell therapies by integrating cellular and molecular biology, immunology, bioengineering, computational approaches and data science. Our scientists work at the interface of experimental science and emerging technologies, bringing curiosity, collaboration and a data-driven mindset to the discovery of innovative cell therapies.  About the Gaithersburg Site   Our Gaithersburg, Maryland campus is a major U.S. hub for R&D and Oncology, bringing together multidisciplinary scientists, modern laboratories and cross-functional teams to advance innovative medicines from discovery through development. The collaborative environment enables scientists with diverse expertise to work together, leverage cutting-edge technologies and translate scientific discoveries into meaningful advances for patients.  Position Summary   This is a predominantly laboratory-based discovery position focused on the in vitro generation, characterization and functional evaluation of engineered immune-cell therapies. The successful candidate will provide hands-on experimental support to CAR-T projects while contributing to Cell Therapy platform capabilities that can be applied across programs.  In this role, you will combine T- and NK-cell biology, cellular engineering, functional assay development and multiparameter flow cytometry to address key biological and translational questions. You will design and execute experiments with increasing independence, analyze and interpret experimental data, and translate findings into clear conclusions and next steps.  Working within multidisciplinary project teams, you will collaborate across Cell Therapy, Bioscience, Bioengineering, Computational Biology, In Vivo Pharmacology. You will also use fit-for-purpose digital and AI-enabled tools to support data organization, analysis, visualization, literature synthesis and experimental planning, while remaining directly engaged in laboratory research.  Key Responsibilities   • Conduct, troubleshoot, analyze independently in vitro Cell Therapy and immunology experiments.  •  Culture and characterize primary T and NK cells, including phenotyping and functional assays.  •  Engineer T cells using viral and/or non-viral approaches.  •  Contribute to Cell Therapy platform development by establishing, optimizing and applying reusable assays, workflows, controls and data-analysis approaches across programs.  •  Design and execute immune-cell functional assays, including activation, cytotoxicity, proliferation, cytokine production, serial or repeated challenge, phenotype, fitness, persistence and other relevant readouts.  •  Plan and perform multiparameter flow cytometry experiments, including panel design, staining, acquisition, quality control, analysis and biological interpretation.  •  Apply cellular and molecular methods relevant to CAR-T discovery, including primary-cell isolation and culture, transfection or electroporation, viral transduction, gene-editing support and molecular characterization.  •  Support in vitro assessment of allogeneic rejection biology, including host-versus-graft and graft-versus-host responses, using immune-cell co-culture, mixed lymphocyte reaction or related assa

Apply on employer site ↗